131 related articles for article (PubMed ID: 1372605)
1. Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product.
Hartman J; Huang Z; Rado TA; Peng S; Jilling T; Muccio DD; Sorscher EJ
J Biol Chem; 1992 Apr; 267(10):6455-8. PubMed ID: 1372605
[TBL] [Abstract][Full Text] [Related]
2. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein.
Ko YH; Thomas PJ; Delannoy MR; Pedersen PL
J Biol Chem; 1993 Nov; 268(32):24330-8. PubMed ID: 7693699
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.
Logan J; Hiestand D; Daram P; Huang Z; Muccio DD; Hartman J; Haley B; Cook WJ; Sorscher EJ
J Clin Invest; 1994 Jul; 94(1):228-36. PubMed ID: 7518829
[TBL] [Abstract][Full Text] [Related]
4. Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.
Teem JL; Berger HA; Ostedgaard LS; Rich DP; Tsui LC; Welsh MJ
Cell; 1993 Apr; 73(2):335-46. PubMed ID: 7682896
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene.
Dörk T; Wulbrand U; Richter T; Neumann T; Wolfes H; Wulf B; Maass G; Tümmler B
Hum Genet; 1991 Aug; 87(4):441-6. PubMed ID: 1715308
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein.
Arispe N; Rojas E; Hartman J; Sorscher EJ; Pollard HB
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1539-43. PubMed ID: 1371876
[TBL] [Abstract][Full Text] [Related]
7. Interaction of nucleotides with membrane-associated cystic fibrosis transmembrane conductance regulator.
Travis SM; Carson MR; Ries DR; Welsh MJ
J Biol Chem; 1993 Jul; 268(21):15336-9. PubMed ID: 7687995
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog.
Bompadre SG; Li M; Hwang TC
J Biol Chem; 2008 Feb; 283(9):5364-9. PubMed ID: 18167357
[TBL] [Abstract][Full Text] [Related]
9. 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator.
Cohen BE; Lee G; Jacobson KA; Kim YC; Huang Z; Sorscher EJ; Pollard HB
Biochemistry; 1997 May; 36(21):6455-61. PubMed ID: 9174362
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis transmembrane conductance regulator: nucleotide binding to a synthetic peptide.
Thomas PJ; Shenbagamurthi P; Ysern X; Pedersen PL
Science; 1991 Feb; 251(4993):555-7. PubMed ID: 1703660
[TBL] [Abstract][Full Text] [Related]
11. The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.
Aleksandrov L; Aleksandrov AA; Chang XB; Riordan JR
J Biol Chem; 2002 May; 277(18):15419-25. PubMed ID: 11861646
[TBL] [Abstract][Full Text] [Related]
12. A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms.
Yike I; Ye J; Zhang Y; Manavalan P; Gerken TA; Dearborn DG
Protein Sci; 1996 Jan; 5(1):89-97. PubMed ID: 8771200
[TBL] [Abstract][Full Text] [Related]
13. Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator.
Aleksandrov L; Mengos A; Chang X; Aleksandrov A; Riordan JR
J Biol Chem; 2001 Apr; 276(16):12918-23. PubMed ID: 11279083
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta f508.
DeCarvalho AC; Gansheroff LJ; Teem JL
J Biol Chem; 2002 Sep; 277(39):35896-905. PubMed ID: 12110684
[TBL] [Abstract][Full Text] [Related]
15. The cystic fibrosis transmembrane conductance regulator. Nucleotide binding to a synthetic peptide segment from the second predicted nucleotide binding fold.
Ko YH; Thomas PJ; Pedersen PL
J Biol Chem; 1994 May; 269(20):14584-8. PubMed ID: 7514174
[TBL] [Abstract][Full Text] [Related]
16. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
[TBL] [Abstract][Full Text] [Related]
17. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells.
Lukacs GL; Chang XB; Bear C; Kartner N; Mohamed A; Riordan JR; Grinstein S
J Biol Chem; 1993 Oct; 268(29):21592-8. PubMed ID: 7691813
[TBL] [Abstract][Full Text] [Related]
18. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.
Pind S; Riordan JR; Williams DB
J Biol Chem; 1994 Apr; 269(17):12784-8. PubMed ID: 7513695
[TBL] [Abstract][Full Text] [Related]
19. A deletion mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) locus: Delta I507.
Schwarz M; Summers C; Heptinstall L; Newton C; Markham A; Super M
Adv Exp Med Biol; 1991; 290():393-8. PubMed ID: 1719770
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of the nucleotide-binding site of the uncoupling protein from hamster brown adipose tissue.
Winkler E; Klingenberg M
Eur J Biochem; 1992 Jan; 203(1-2):295-304. PubMed ID: 1730236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
